Every dollar amount and date on this page is quoted from the official settlement document.
Athira
Court case: Athira Pharma Securities Litigation
Athira Pharma, a biotech developing an Alzheimer's treatment, was sued after allegations surfaced about manipulated research images used to support the company's science, and investors said the news drove the stock down. The case settled for a $10,000,000 cash fund covering stock bought between September 17, 2020 and June 17, 2021. The claim deadline passed in September 2024, and the case is now closed.
Official eligibility wordingPersons who purchased or otherwise acquired Athira Pharma, Inc. publicly traded common stock during the class period (September 17, 2020 through June 17, 2021) and were damaged thereby. Checked against the official settlement source by SettleSignal on June 19, 2026.
Key facts
- Who may qualify Investors who purchased or otherwise acquired Athira Pharma publicly traded common stock between September 17, 2020 and June 17, 2021 were part of the class.
- Estimated payout$10,000,000 in cash
- Claim deadlineSeptember 6, 2024 (closed)
- Proof requiredYes
- What you needClaims were due by September 6, 2024; that deadline has passed and no further claims are being taken.
- CourtUnited States District Court for the Western District of Washington
Important dates
How hard is this claim to file?
Watch out for
- The claims filing deadline has passed; the settlement website states 'The claims filing deadline for this case has passed'
- Only class members who submitted valid claim forms by the deadline are eligible for payments
- If you opted out of the class by submitting a written exclusion request, you are not eligible for settlement benefits
We prepare — you file on the official site yourself. This is not legal advice and is not an eligibility decision; the administrator and court decide.
Verify it yourself
How we verified this record
- Claim deadline Jun 18, 2026
- Payout details Jun 18, 2026
- Eligibility Jun 18, 2026
- Proof requirement Jun 18, 2026
- Administrator Jun 19, 2026
- Court case Jun 18, 2026
- Payment status Jun 18, 2026
- 1 field queued for re-check
6 official sources linked to this record.
-
Claim deadline
September 6, 2024
Verified Jun 18, 2026
-
Eligibility summary Quoted in the official eligibility wording above ↑
Verified Jun 18, 2026
-
Proof requirement
Yes
Verified Jun 18, 2026
-
Payment status
Final approval pending
Verified Jun 18, 2026
The Court has granted Plaintiffs' unopposed motion for final approval of the Settlement. Class members who submitted valid claim forms by the deadline are eligible for payments from the settlement fund.
-
Estimated payout
$10,000,000 in cash
Verified Jun 18, 2026
-
Administrator
Strategic Claims Services
Verified Jun 19, 2026
Show all 7 more verified fields
-
Objection deadline
September 6, 2024
Verified Jun 18, 2026
BY SEPTEMBER 6, 2024 IF YOU ARE NOT REPRESENTED BY COUNSEL. BY OCTOBER 11, 2024 IF YOU ARE REPRESENTED BY COUNSEL.
-
Opt-out deadline
September 6, 2024
Verified Jun 18, 2026
-
Class period start
September 17, 2020
Verified Jun 18, 2026
-
Class period end
June 17, 2021
Verified Jun 18, 2026
-
Court
United States District Court for the Western District of Washington
Verified Jun 18, 2026
-
Court case number
2:21-Cv-00861-TSZ
Verified Jun 18, 2026
Case No. 2:21-Cv-00861-TSZ (W.D. Wash.)
-
Case name
Athira Pharma Securities Litigation
Verified Jun 19, 2026
Where to act
